- Galena Biopharma Inc GALE shares dropped 85 percent to $0.310 after the company reported the discontinuation of Phase 3 PRESENT clinical trial due to futility of study.
- Lipocine Inc LPCN shares tumbled 51.8 percent to $3.03 following announcement of a Complete Response Letter from the FDA. The response letter noted deficiencies in dosing algorithm on label.
- Esperion Therapeutics Inc ESPR shares fell 38.2 percent to $9.99 after failing to reach an agreement with the FDA regarding a definitive approval path for its ETC-1002, a cholesterol-lowering pill. JP Morgan downgraded Esperion Therapeutics from Overweight to Neutral and lowered the price target from $50.00 to $15.00, while Credit Suisse also downgraded the stock from Neutral to Underperform and lowered the price target from $23.00 to $10.00.
- Eclipse Resources Corp ECR shares declined 16 percent to $3.45. Eclipse Resources reported an offering of 37.5 million shares of common stock. The company also raised its production guidance to 205-210 MMcfe per day for 2016.
- Kitov Pharmaceuticals Holdings Ltd (ADR) KTOV shares dropped 10 percent to $3.05 as the company reported the pricing of its $12 million follow-on public offering in the U.S.A.
- China Ceramics Co Ltd CCCL shares fell 7.4 percent to $2.64 after the company reported the settlement of class action litigation.
- Southwestern Energy Company SWN shares slipped 5 percent to $13.19. Southwestern Energy reported a 75 million share offering to replay part of loan.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
